South Korea Biotechnology & Medical Research

Kanaph Therapeutics Inc (0082N0)

Kanaph Therapeutics recorded a single purchase transaction during the past ninety days. Vice President Changwon Park acquired shares valued at 26.7 million KRW on October 30, 2026. This solitary buy represents the entirety of recent insider activity, occurring without any corresponding sales or public disclosure regarding a recent earnings report.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: 0082N0 Exchange: KOE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Kanaph Therapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Changwon Park (박창원) Vice President (부사장) Officer

Transaction date 30 Oct 2026

Purchase

Price

345.45

Quantity 48,776 -28.3%

Value ₩2,767,565

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-11-02	2026-10-30	B Purchase	Changwon Park (박창원) Vice President (부사장) Officer	48,776 -28.3% 345.45 ₩2,767,565	48,776 -28.3%	345.45	₩2,767,565